Clovis Oncology Submits Applications for Rubraca® Label Expansion in the US and European Union as First-line Maintenance Treatment in Women with Advanced Ovarian Cancer
Stock Information for Clovis Oncology Inc.
Loading
Please wait while we load your information from QuoteMedia.